sinc
emerg
pandem
viru
mexico
california
biannual
increas
number
case
detect
mexico
first
outbreak
began
late
march
juli
follow
second
wave
late
august
march
winter
season
character
low
case
pandem
viru
predomin
influenza
influenza
b
observ
previou
season
pandem
viru
detect
sever
case
winter
season
final
winter
season
becam
preval
influenza
viru
increas
case
pneumonia
hospit
observ
nation
institut
respiratori
diseas
mexico
citi
season
case
relat
presenc
pandem
viru
molecular
phylogenet
analys
viral
genom
necessari
determin
antigen
pathogen
characterist
influenza
virus
caus
sever
outcom
diseas
context
one
first
studi
mexico
analyz
sequenc
ha
na
pandem
viru
done
earli
day
pandem
outbreak
detect
monitor
pathogen
resist
substitut
affect
outcom
sever
respiratori
diseas
later
oseltamivirresist
viru
observ
show
low
rate
substitut
regard
pathogen
substitut
associ
sever
mortal
patient
mexico
citi
mutat
associ
adapt
increas
pathogen
human
avian
influenza
viru
detect
introduct
differ
substitut
segment
particularli
ha
gene
segment
might
affect
immunogen
pandem
viru
importantli
strain
recommend
world
health
organ
vaccin
composit
remain
influenza
season
northern
hemispher
winter
suggest
pandem
viru
undergon
antigen
chang
sever
year
circul
antigen
drift
caus
mutat
antigen
site
adjac
receptor
bind
site
ha
monitor
molecular
function
properti
ha
becom
essenti
effect
vaccin
develop
previou
data
show
substitut
near
immunogen
domain
ha
appear
sinc
probabl
compromis
effect
vaccin
report
ha
pandem
viru
character
season
report
also
identifi
substitut
might
affect
region
ha
target
antibodi
middleag
adult
recent
extens
studi
global
evolut
pandem
influenza
report
howev
whole
ha
sequenc
mexico
includ
furthermor
influenza
season
delay
wave
pandem
confirm
case
observ
march
signific
increas
sever
case
mexico
citi
hospit
observ
paper
analyz
evolut
antigen
genet
drift
mexican
isol
begin
pandem
clinic
sampl
patient
influenzalik
ill
collect
iner
part
routin
care
diagnosi
sampl
collect
nasopharynx
swab
bronchial
aspir
clinic
sampl
type
use
specif
primer
influenza
b
sampl
posit
influenza
viru
use
rna
extract
ul
sampl
invisorb
extract
column
use
sampl
obtain
nasal
swab
invisorb
spin
viru
mini
kit
cat
viral
type
perform
rtpcr
accord
center
diseas
control
cdc
guidelin
approv
studi
obtain
ethic
research
institut
board
nation
institut
genom
medicin
ethic
research
board
nation
institut
respiratori
diseas
inform
consent
provid
accord
declar
helsinki
written
inform
consent
obtain
studi
patient
andor
rel
author
legal
repres
clinic
sampl
posit
obtain
whole
viral
genom
sequenc
sampl
sampl
sequenc
use
highdens
oligonuclotid
microarray
sampl
sequenc
use
massiv
parallel
sequenc
illumina
platform
sampl
sequenc
use
technolog
addit
sampl
could
achiev
whole
genom
sequenc
obtain
sequenc
specif
segment
inmegenin
np
ns
inmegenin
np
ns
inmegenin
segment
except
ha
viral
segment
amplifi
simultan
directli
clinic
sampl
use
primer
describ
elsewher
amplif
product
sampl
gelpurifi
qiaquick
gel
extract
kit
qiagen
valencia
ca
barcod
librari
ng
produc
use
nextera
xt
dna
librari
prepar
kit
pairedend
sequenc
cycl
perform
use
miseq
platform
illumina
read
map
data
obtain
niaid
influenza
research
databas
ird
access
number
sequenc
present
tabl
use
smalt
assembl
perform
use
velvet
packag
velvet
visual
tablet
v
coverag
achiev
viru
least
depth
ha
ns
na
np
segment
mean
coverag
pa
segment
coverag
sequenc
studi
deposit
niaid
influenza
research
databas
ird
http
wwwfludborg
avail
genbank
acces
number
found
tabl
sequenc
analyz
use
amino
acid
sequenc
refer
compar
global
sequenc
flusurv
eight
viral
segment
access
number
tabl
order
identifi
novel
substitut
determin
mani
time
report
substitut
previous
report
sequenc
align
use
clustal
w
method
molecular
evolutionari
genet
analysi
mega
softwar
analysi
substitut
ha
carri
use
refer
sequenc
establish
chang
antigen
site
neighbor
posit
clinic
sampl
sequenc
year
substitut
obtain
manual
search
align
sequenc
mega
fulllength
nucleotid
sequenc
select
segment
human
influenza
virus
report
decemb
ird
includ
genom
correspond
segment
includ
ten
whole
genom
sequenc
studi
analys
viral
segment
sequenc
pa
ha
np
na
ns
clinic
sampl
collect
sampl
whole
genom
sequenc
data
sequenc
align
creat
multipl
sequenc
comparison
logexpect
muscl
edit
mega
maximum
likelihood
tree
construct
influenza
segment
use
mega
tajimanei
model
select
gamma
distribut
rate
bootstrap
replic
edit
tree
made
use
tree
http
treebioedacuksoftwarefigtre
substitut
observ
whole
genom
pandem
viru
classifi
viral
gene
segment
year
isol
descript
mutat
analysi
sequenc
eight
viral
segment
perform
use
strain
amino
acid
sequenc
refer
compar
global
sequenc
flusurv
tabl
show
substitut
detect
viral
segment
correspond
viral
gene
ha
np
na
pa
correspond
year
detect
ital
bold
potenti
biolog
effect
substitut
identifi
novel
potenti
biolog
role
defin
substitut
previous
report
involv
host
specif
shift
viral
oligomer
interfac
voi
bind
small
ligand
bsl
ab
recognit
bind
host
protein
bhp
bind
nucleic
acid
bna
antigen
drift
voi
calcul
automat
known
structur
captur
site
viral
oligomer
site
well
crystal
contact
bhp
includ
mostli
interact
human
immun
respons
protein
bsl
deriv
small
ligand
seen
known
crystal
structur
case
influenza
surfac
protein
often
signifi
interact
small
glycan
near
glycosyl
site
sequenc
segment
ha
np
na
ns
pandem
viru
collect
influenza
season
cluster
sequenc
new
york
helsinki
washington
howev
polymeras
complex
sequenc
cluster
sampl
analysi
base
ha
gene
show
mexican
sequenc
could
divid
group
group
sequenc
form
monophylet
group
bootstrap
fig
mexican
sequenc
cluster
next
ha
sequenc
strain
new
york
bootstrap
valu
sequenc
share
two
substitut
signal
peptid
immatur
ha
amino
acid
vi
group
sequenc
cluster
separ
share
novel
substitut
ha
group
cluster
strain
isol
new
york
washington
helsinki
one
isol
share
mutat
sequenc
helsinki
finland
princip
map
amino
acid
substitut
occur
node
ha
phylogeni
reveal
amino
acid
chang
sequenc
report
previous
addit
cluster
mexican
sequenc
mark
substitut
regard
na
observ
substitut
mark
sequenc
determin
whether
individu
site
posit
select
use
mix
effect
model
evolut
meme
method
statist
signific
p
addit
found
substitut
distinguish
three
group
mention
ha
analys
observ
substitut
group
found
group
substitut
present
sequenc
group
detect
substitut
group
group
final
substitut
group
regard
pa
found
substitut
signatur
group
statist
signific
p
group
detect
two
substitut
associ
substitut
group
group
found
group
substitut
found
np
similar
report
countri
tabl
map
substitut
antigen
site
show
differ
pattern
chang
winter
season
ha
substitut
domin
mutat
influenza
season
mutat
becam
domin
sinc
remain
addit
substitut
domin
influenza
viru
mexico
importantli
detect
substitut
locat
antigen
region
ha
relev
immunogen
site
fig
six
put
glycosyl
site
ha
asnxaaserthr
posit
predict
use
netnglyc
server
indic
mexican
isol
maintain
glycosyl
pattern
similar
california
influenza
virus
caus
acut
respiratori
tract
infect
repres
signific
public
health
threat
outbreak
strain
swineorigin
influenza
viru
infect
still
circul
winter
season
mani
countri
may
caus
sever
pulmonari
ill
suscept
individu
therefor
continu
analysi
entir
genom
virus
provid
comprehens
inform
molecular
evolut
order
maintain
effect
prevent
measur
public
health
extens
demonstr
pandem
influenza
viru
contain
mixtur
segment
includ
ha
np
pa
ns
tripl
reassort
viru
isol
north
america
segment
na
eurasian
swine
influenza
viru
due
differenti
mutat
rate
viral
segment
molecular
epidemiolog
surveil
import
detect
antigen
variat
among
circul
influenza
strain
modifi
pathogen
antivir
resist
pattern
viral
strain
studi
sequenc
entir
genom
pandem
strain
isol
patient
refer
hospit
mexico
citi
iner
differ
year
compar
sequenc
consensu
sequenc
order
detect
mutat
might
associ
viral
evolut
might
influenc
antigen
viru
import
mention
sequenc
obtain
directli
clinic
sampl
order
avoid
vitro
artifici
select
found
clear
variat
viru
mexico
season
due
differ
marker
accord
previou
report
mutat
pa
np
na
ha
appear
togeth
evolut
influenza
viru
mexico
howev
found
uniqu
substitut
ha
na
mexican
strain
could
indic
geograph
diverg
find
confirm
sequenc
obtain
region
countri
recent
extens
analysi
sequenc
influenza
viru
postpandem
era
show
differ
geograph
region
gener
local
epidem
peak
might
act
potenti
seed
local
viru
studi
would
requir
order
determin
fix
next
gener
influenza
viru
mexico
known
influenza
virus
undergo
posit
select
process
crossspeci
transmiss
initi
stage
human
outbreak
follow
purifi
neg
select
virus
adapt
new
human
host
late
epidem
context
still
observ
posit
select
substitut
na
pa
winter
season
data
indic
polymeras
complex
appear
differ
evolutionari
dynam
probabl
due
differ
evolutionari
rate
among
viral
segment
might
also
reflect
differ
select
pressur
viru
infect
host
regard
rest
viral
genom
segment
mexican
isol
season
cluster
sequenc
new
york
helsinki
mexican
sequenc
belong
clade
character
substitut
fig
howev
differ
branch
observ
sequenc
present
specif
substitut
segment
includ
substitut
lie
antigen
site
ha
result
suggest
strain
could
appear
temporarili
differ
molecular
characterist
potenti
antigen
pathogen
implic
recent
signific
chang
occur
viru
substitut
predomin
year
associ
bind
prevent
antibodi
ab
elicit
larger
number
middleag
human
world
studi
identifi
novel
substitut
import
biolog
effect
includ
virul
cell
epitop
present
mhc
potenti
role
host
specif
shift
note
although
mutat
particularli
character
found
close
belong
region
biolog
import
previous
tabl
substitut
posit
r
implic
effici
replic
pandem
virus
mammal
effect
prolin
known
part
epitop
might
affect
effici
antigen
process
cytotox
lymphocyt
ctl
respons
ntermin
ectodomain
outsid
viral
membran
near
disulfid
bridg
connect
tetram
specif
effect
particularli
character
yet
novel
substitut
report
involv
voi
pa
posit
bsl
pa
voibna
np
bslvoi
regard
previous
observ
substitut
comput
predict
link
host
specif
role
residu
includ
voi
pa
np
bsl
pa
observ
substitut
might
one
biolog
function
ha
implic
ab
recognit
bsl
voi
bhp
na
also
associ
antigen
drift
bslvoi
pa
na
bhp
na
involv
bsl
relat
bsl
voi
bna
np
relat
voi
site
describ
crystalograph
comput
analysi
tabl
ha
observ
chang
could
affect
immunogen
influenza
viru
sequenc
addit
mutat
antigen
site
sa
togeth
substitut
defin
new
clade
importantli
may
confer
addit
glycosyl
site
ha
could
affect
even
immunogen
influenza
viru
futur
result
indic
pandem
influenza
viru
chang
season
show
use
whole
genom
sequenc
abl
provid
deeper
understand
viru
evolut
time
